Bankrupt hospital operator Promise Healthcare Group LLC filed a motion Tuesday in Delaware seeking approval of sale procedures for its remaining assets after reaching agreements on transactions for most of its larger properties.
A Chinese online brokerage plus three biotechnology companies filed plans after Christmas for initial public offerings tentatively estimated to raise $572 million combined, moving ahead with deals that could price this month, assuming choppy markets don’t scare off issuers.
The Ohio federal judge overseeing the opioid multidistrict litigation has issued an order creating a second track of bellwether cases, saying the first track of cases represents a large but incomplete portion of the issues relevant to the litigation.
A New Jersey state appeals court on Wednesday refused to revive a medical malpractice action alleging two doctors injured a man during a surgical procedure at the time of his birth in 1995, saying he had to bring the suit by his 20th birthday but did not file it until he turned 21.
Health care-focused real estate investment trust Omega Healthcare Investors Inc. on Wednesday said it will take over fellow REIT MedEquities Realty Trust Inc. in a $600 million deal, with Bryan Cave Leighton Paisner LLP and Morrison & Foerster LLP steering the buyer and seller, respectively.
The former chief executive of Insys Therapeutics has agreed to plead guilty to conspiracy and mail fraud for his role in a scheme to bribe doctors to prescribe the company's fentanyl-based painkillers, prosecutors said in a court filing.
A leadership transition in Florida, with a new governor, House speaker and Senate president, has produced an optimistic outlook — and even hints of bipartisanship — for moving beyond a challenging year in 2018 and tackling pressing issues regarding health care, the environment, medical marijuana and insurance in 2019, according to lawyers and government specialists.
Health care providers and insurers in 2019 will confront an eye-popping array of regulatory endeavors, including a new "blacklist" that shames accused fraudsters, an expansion of kickback liability, and potentially dramatic changes to Medicare reimbursement. Here, Law360 explains health policy developments that lawyers need to track in the year ahead.
A bellwether merger appraisal appeal, a spotlight on “enhanced” director independence, a trial over a mega-merger meltdown and an appeal from a rare deployment of the “implied covenant” in a contract dispute all lay ahead as 2019 opens in Delaware’s Chancery and Supreme Courts.
As more states legalize recreational and medical cannabis, more litigation has popped up around the industry. From what is likely the country’s first cannabis patent suit to a wave of civil claims filed by people living near growers and distributors, courts are being asked to decide a variety of disputes that touch on the clash between federal and state laws governing cannabis. Here are several cases in the cannabis world that Law360 is watching in 2019.
In the new year, Native American law practitioners will be keeping an eye on upcoming U.S. Supreme Court decisions regarding Washington's ability to tax the Yakama Nation; treaty hunting rights in Wyoming; and the balance of tribal, federal and state criminal jurisdiction in Oklahoma. Here, Law360 takes a look at the cases attorneys who practice Native American law will be watching in the coming year.
The coming year's white collar docket is an active one, with several large health care fraud cases set to go to trial and post-trial litigation that could shape the law in insider trading and other financial crimes and affect how companies cooperate in criminal probes.
The health care industry in 2019 will watch with bated breath as a guillotine hangs over the Affordable Care Act, historic litigation involving the opioid crisis heads to trial and the murky meaning of a landmark False Claims Act decision becomes clearer. Here, Law360 gets attorneys up to speed on must-watch cases in the year ahead.
A U.S. Supreme Court case that will decide whether a federally owned utility can be sued for personal injury and a Texas high court medical malpractice dispute that could change standards for expert witness testimony are among the cases that personal injury and medical malpractice attorneys will be following in 2019.
The antitrust cases likely to dominate 2019 are for the most part continuations of 2018’s biggest cases, including contentious disputes over technology patent licensing, enforcement actions targeting makers of brand-name and generic drugs, and the U.S. Department of Justice’s efforts to block the AT&T-Time Warner merger.
Texas’ fights to end the Deferred Action for Childhood Arrivals program and hold opioid manufacturers to task for alleged deceptive marketing will continue to make legal waves in 2019, while Texas Attorney General Ken Paxton is yet again waiting out a potential trial on securities fraud charges.
The life sciences industry will be keeping an eye on courtrooms around the country in 2019, watching to see how the U.S. Supreme Court decides a legal battle over patent protection for drugs and monitoring the fallout from federal prosecutors’ decision to spike a False Claims Act case. Here are seven cases life sciences attorneys say they'll be following in the coming year.
Benefits attorneys will be waiting to see if the new year brings a solution to the multiemployer pension crisis, a substitute for the U.S. Department of Labor’s controversial fiduciary rule or clarity on how a pair of regulations will impact group health offerings and employee retirement savings. Here, Law360 breaks down four policy developments headlining what promises to be a busy year for benefits lawyers.
From the trial court level all the way up to the Supreme Court, the Pennsylvania judiciary is looking at a busy year ahead with major litigation teed up over the extent of the state’s jurisdiction over foreign corporations, the statute of limitations in sex abuse cases against the Roman Catholic Church, and overtime obligations for employers.
Product liability attorneys are closely watching two appeals at the U.S. Supreme Court — one over Merck's osteoporosis drug Fosamax and another involving asbestos and maritime law — as well as the enormous multidistrict litigation over the opioid crisis and suits alleging that Monsanto’s weedkiller Roundup causes cancer. Here, Law360 summarizes the top cases product liability attorneys will be following in 2019.
Predicting how the cybersecurity landscape will develop is critical for any organization wanting to mitigate the risk of the inevitable future attack. Michael Hall of HighQ Solutions Ltd. discusses five threats to look out for in the next 12 months.
On Oct. 23, the departments of Treasury, Labor and Health and Human Services released long-awaited guidance that would allow employees to use health reimbursement arrangement funds to buy their own health insurance. Attorneys at Groom Law Group examine the proposed regulations and the implications for taxpayers should they become final.
Joshua Peck, incoming marketing director of Hill Wallack LLP, traces the evolution of the chief marketing officer position at law firms and shares insights from three legal marketing pioneers.
Now that the results of the 2018 election are (mostly) in, Evan Migdail and Melissa Gierach at DLA Piper LLP consider what a Democratic House, Republican Senate and Trump administration may be able to accomplish in the way of tax policy during the lame-duck session and the upcoming 116th Congress.
In this monthly series, Amanda Brady of Major Lindsey & Africa interviews management from top law firms about the increasingly competitive business environment. Here we feature Katie DeBord, chief innovation officer at Bryan Cave Leighton Paisner LLP.
As demonstrated by a recently filed class action against a hospital housekeeping company in Illinois federal court — Byczek v. Xanitos — the ever-changing legal landscape surrounding biometric data should give employers pause when considering its use in the workplace, say Robert Quackenboss and Madalyn Doucet of Hunton Andrews Kurth LLP.
With few cases going to trial, many attorneys keep their oral-presentation skills sharp by teaching continuing legal education programs. To avoid giving a CLE that falls flat and damages your reputation, you must fashion a thoughtful message, control its presentation, and nail the beginning and ending, says Daniel Karon of Karon LLC.
Courts are increasingly upholding involuntary releases of third parties and nondebtors in bankruptcy, including recently in the case of Millennium Lab Holdings. This means parties should consider several factors when picking a venue for a Chapter 11 filing, say Samuel Schwartz and Kristina Perez of Brownstein Hyatt Farber Schreck LLP.
Since the oldest members of Generation Z aren’t even finished with law school yet, law firm management is in a unique position to prepare for their entrance into the legal workforce, says Eliza Stoker of Major Lindsey & Africa.
In AMN Healthcare v. Aya Healthcare Services, a California appellate court recently held that employee nonsolicitation agreements are void unless they fall within one of three statutory exceptions, clearing up uncertainty about their enforceability in the state, say Dylan Wiseman and Alexandra Grayner at Buchalter PC.